Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating
Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating
奧本海默將製藥集團價格目標調整至 40 美元,從 36 美元維持「跑贏大市」評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊